SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

A nationwide FAA ground stop triggered by an air-traffic-control communications failure is driving attention to Delta and other airlines, with delays and cancellations continuing after the restriction was lifted. Traders are weighing near-term operational costs against views that the outage is temporary; cyberattack claims remain speculation, not a confirmed cause.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.0099454 USD and is down -2.36 over the last 24 hours. It is currently trading on 1896 active market(s) with $2,532,309,467.05 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

A broad crypto-market selloff has pushed XRP below a key psychological support level, intensifying concern about further losses. Traders are split between warning of continued downside and treating the decline as a buying opportunity, with some alleging whale accumulation but no clear catalyst-specific confirmation in the discussion.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

A nationwide FAA ground stop triggered by an air-traffic-control communications outage pressured AAL and other airlines, with delays and cancellations continuing after flights resumed. Traders mostly debated whether the disruption is a temporary operational hit or a bigger concern; speculation about a cyberattack or other cause remains unverified.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

The CHMP reaffirmed its negative opinion on Zevras European marketing application for Miplyffa (arimoclomol), prompting a sharp selloff as traders weighed the loss of European-market prospects against the pending European Commission decision. Some see the drop as an overreaction because Miplyffa is already approved in the U.S.; others cite regulatory and management concerns, while buyout speculation persists.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXOs quarterly results are driving discussion: traders point to improving margins and the newly authorized share repurchase, but the stocks decline has some focused on rising operating costs, debt, and sensitivity to interest rates and housing demand. Views are split between investors who see progress in integrating acquisitions and those who see few near-term catalysts.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,631. The last known price of Bitcoin is 68,229.80907922 USD and is down -4.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $42,739,134,877.94 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and break below key technical support levels dominate the discussion, with traders debating whether the decline signals a deeper bear market or an oversold dip that could rebound. Some also point to macroeconomic pressure, including a stronger dollar and higher yields, while others argue that dip buyers are absorbing the selling.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinias ongoing patent litigation with generic challengers is the main focus, with recent court filings and deadline extensions prompting speculation about settlement or further delays. Traders are divided between optimism about patent protection and frustration over uncertainty and managements lack of communication.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Labs 100th Electron launch drew excitement, with traders celebrating a flawless milestone flight. The discussion also weighs strong revenue and backlog growth against Neutrons delay into 2027, with bulls focused on demand and bears concerned about execution, losses and valuation.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

The FAAs rare nationwide flight ground stop has prompted speculation among some traders that the unexplained communications issue could have a cybersecurity angle, though no cyberattack has been confirmed. Bullish posters say the incident underscores demand for cybersecurity providers such as SentinelOne.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POETs Q3 results and outlook are the dominant focus, with investors looking for concrete evidence of customer orders, shipments, and a production ramp in its AI-optics business. Bulls hope for encouraging commercialization updates, while skeptics expect limited visibility and worry that continued delays will weigh on the shares.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Apyx Medical (APYX) Reports Q3 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of +42.86% and +2.94%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Evolus, Inc. (EOLS) Reports Q3 Loss, Beats Revenue Estimates

Evolus (EOLS) delivered earnings and revenue surprises of -80.00% and +1.13%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Apyx Medical Corporation (NASDAQ: APYX)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Apyx Medical Corporation (NASDAQ: APYX) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Apyx Medical Corporation (NASDAQ: APYX)PR NewswireNEW YORK, Oct. 22, 2026 NEW YORK, Oct. 22...

Apyx Medical (APYX) Reports Q2 Loss, Beats Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of -16.67% and +10.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway

Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway PR Newswire CLEARWATER, Fla., May 27, 2026 CLEARWATER...

Apyx Medical (APYX) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of +54.55% and +6.23%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Perrigo (PRGO) Q1 Earnings Beat Estimates

Perrigo (PRGO) delivered earnings and revenue surprises of +10.26% and -4.20%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

1,104,970 Shares in Apyx Medical Corporation $APYX Purchased by AIGH Capital Management LLC

AIGH Capital Management LLC bought a new position in shares of Apyx Medical Corporation (NASDAQ:APYX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 1,104,970 shares of the company's stock, valued at approximately $3,867,000. A...

Apyx Medical (APYX) Expected to Announce Earnings on Thursday

Apyx Medical (NASDAQ:APYX) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-apyx-medical-co-stock...

• Reported GAAP EPS of -$0.04 up 20.00% YoY
• Reported revenue of $14.03M up 8.93% YoY
• Apyx Medical reaffirmed FY2026 revenue guidance of $59M to $60M, expects gross margins of 63% to 65%, and lowered operating expense guidance to $41M to $42.5M from less than $45M.

Apyx Medicals OEM revenue declined 42% and Apyx Medical expects full-year OEM revenue to decrease; operating expenses increased, while domestic standalone generators and single-use handpieces declined globally.

Apyx Medicals Surgical Aesthetics revenue increased 17%; power liposuction launched with positive early adopter feedback; a study reported 30% greater elastin fiber density and 34% less inflammation.

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used by the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Surgical Aesthetics and Original Equipment Manufacturer (OEM). The Surgical Aesthetics segment consists of the Helium Plasma Technology lines, which include Renuvion and J-Plasma. The OEM segment focuses on designing, development, and manufacturing electrosurgical equipment and medical devices by producing generators, medical devices and related accessories. The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Apyx Medical Corp

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$2.81
Prev Close	$2.89
Open	$2.85
Dividend Yield	0.00%
50-Day Moving Average	$2.72
Beta	1.30
Avg. Volume	122,761.15
PE Ratio	-14.52

52-Week High	$5.08
52-Week Low	$2.25
Market Capitalization	$121.74M
EPS (Annual)	-$0.2728
Price to Book	12.29
Revenue Per Employee	$257,775.61

Feed

News

Sentiment

Earnings

Fundamentals

Info

APYX Fundamentals